Sana Biotechnology reports promising immune-evasive islet cell transplant in breakthrough step towards insulin independence

Sana Biotechnology reveals early clinical success with gene-modified pancreatic islet cells that can survive without immunosuppression, marking a potential breakthrough in diabetes treatment. Sana Biotechnology is advancing what it believes could become a functional cure for type 1 diabetes by…













